VOLIOTIS DIMITRIS (SVP, Clinical Development) sold 3.6% of their position (601.00 shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $30.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/14/2022ACC: 0001725160-22-000035
Officer· SVP, Clinical Development
Since Apr 2020
+33.96K
Net shares
Net buyer
$30.2K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
34.56K acquired · 601.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+10.33K
Price / share
—
Trade value
—
% of position
165.3%
2/10/2022
6.25K→16.58K
Common Stock
Direct
Shares
−534.00
Price / share
$50.16
Trade value
$26.79K
% of position
3.2%
2/14/2022
16.58K→16.05K
Common Stock
Direct
Shares
−67.00
Price / share
$50.75
Trade value
$3.40K
% of position
0.4%
2/14/2022
16.05K→15.98K
Total
Net shares
+9.73K
Net value
-$30.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2022 | A · Award | +10.33K | — | — | 165.3% | 6.25K | 16.58K |
| Common Stock Direct | 2/14/2022 | S · Sale | −534.00 | $50.16 | $26.79K | 3.2% | 16.58K | 16.05K |
| Common Stock Direct | 2/14/2022 | S · Sale | −67.00 | $50.75 | $3.40K | 0.4% | 16.05K | 15.98K |
| Total | +9.73K | -$30.19K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
24.23K shares
Shares
+24.23K
Strike price
52.61
Held after
24.23K
Exercisable
—
2/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock24.23K shares | 2/10/2022 | A · Award | +24.23K | 52.61 | — | 24.23K |